New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 25, 2014
09:02 EDTALXAAlexza Pharmaceuticals appoints Robert Lippe as COO
Alexza Pharmaceuticals announced that Robert A. Lippe has joined the Company as Executive Vice President, Operations and COO. In this newly created position, Lippe has responsibility for the Company's global operation functions, including strategic development and execution of clinical and commercial manufacturing, quality and compliance, supply chain and supply partner management, technology transfer, facilities, sustainment engineering and IT in support of the Company's product and technology portfolio. Lippe brings more than two decades of experience in operations with multinational biopharmaceutical companies and national research laboratories.
News For ALXA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 22, 2015
09:11 EDTALXAAlexza Pharmaceuticals initiates Phase 2a study of AZ-002 in epilepsy
Alexza Pharmaceuticals has initiated a Phase 2a study of AZ-002 - Staccato alprazolam -, which is being developed for the management of epilepsy in patients with acute repetitive seizures. ARS occurs in a subset of patients with epilepsy who regularly experience breakthrough seizures, despite treatment with a regular regimen of anti-epileptic drugs. Alexza expects to announce results from this study in 1H15.
09:11 EDTALXAAlexza Pharmaceuticals initiates Phase 2a study of AZ-002 in epilepsy
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use